UK markets closed

NeuroMetrix, Inc. (NURO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.8300+0.0900 (+2.41%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-7,985
-6,529
-4,417
-2,281
-2,092
-
Depreciation & amortisation
70.398
55.712
49.391
76.378
89.954
-
Stock-based compensation
750.308
699.505
477.062
698.173
599.117
-
Change in working capital
641.399
126.204
-1,713
-1,233
-1,057
-
Accounts receivable
106.631
127.947
-335.953
23.479
-35.33
-
Inventory
202.468
-7.861
-1,265
-154.412
112.432
-
Accounts payable
-255.746
-152.573
84.046
141.72
-583.342
-
Other working capital
-7,228
-6,268
-5,313
-2,205
-2,067
-
Other non-cash items
-
-135.293
-50.171
-
43.751
-
Net cash provided by operating activities
-7,045
-6,085
-5,289
-2,074
-2,067
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-183.542
-23.182
-131.71
-
-48.076
Purchases of investments
-27,780
-29,755
-40,933
0
-
-
Sales/maturities of investments
30,095
31,095
24,145
0
-
-
Net cash used for investing activities
2,132
1,156
-16,812
-131.71
0
-
Cash flows from financing activities
Debt repayment
-
-
-
0
-773.2
0
Common stock issued
3,797
2,325
3,864
19,551
4,167
-
Net cash used provided by (used for) financing activities
3,797
2,325
3,864
19,551
4,167
-
Net change in cash
-1,117
-2,603
-18,237
17,346
2,100
-
Cash at beginning of period
2,377
4,335
22,572
5,226
3,126
-
Cash at end of period
1,260
1,732
4,335
22,572
5,226
-
Free cash flow
Operating cash flow
-7,045
-6,085
-5,289
-2,074
-2,067
-
Capital expenditure
-
-183.542
-23.182
-131.71
-
-48.076
Free cash flow
-7,228
-6,268
-5,313
-2,205
-2,067
-